Aion Therapeutic (XCNQ:AION) 5-Year EBITDA Growth Rate : 24.40% (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic 5-Year EBITDA Growth Rate?

Aion Therapeutic's EBITDA per Share for the three months ended in Jan. 2024 was C$-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 47.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 24.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Aion Therapeutic was 47.70% per year. The lowest was -177.00% per year. And the median was 45.10% per year.

Competitive Comparison of Aion Therapeutic's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Aion Therapeutic's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aion Therapeutic's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aion Therapeutic's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Aion Therapeutic's 5-Year EBITDA Growth Rate falls into.

Aion Therapeutic 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Aion Therapeutic (XCNQ:AION) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Aion Therapeutic 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Aion Therapeutic (XCNQ:AION) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ANTCF:USA

Address

700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8

Website

https://www.aiontherapeutic.com

Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.

Executives

Ismail Abdul Fattah

Director or Senior Officer of 10% Security Holder

Aion Therapeutic (XCNQ:AION) Headlines

No Headlines